Self-peptide ligands affect T cell recognition of the homologous influenza A matrix virus peptide M.58-66: Modification of the HLA- A2.1/peptide complex structure and T cell antagonism

Human Immunology

Volumn 54, Issue 1, 1997, Pages 48-53

  Hlavac, Frédéric ^a   Choppin, Jeannine ^a   Guillet, Jean Gérard ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; MATRIX PROTEIN; VIRUS ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; T LYMPHOCYTE ACTIVATION;

AUTOANTIGENS; CYTOTOXICITY, IMMUNOLOGIC; HLA-A2 ANTIGEN; HUMANS; INFLUENZA A VIRUS; LIGANDS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EID: 0030928347     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00006-2     Document Type: Article

References (24)

1. De Magistris MT, Alexander J, Coggeshall M, Altman A, Gaeta FCA, Grey HM, Sette A. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68:1992;625.
2. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature. 363:1993;156.
3. Bednarek MA, Sauma SY, Gammon MC, Porter G, Tamhankar S, Williamson AR, Zweerink HJ. The minimum peptide epitope from the influenza virus matrix protein. J Immunol. 147:1991;4047.
4. Morrison J, Elvin J, Latron F, Gotch F, Moots R, Strominger JL, McMichael AJ. Identification of the nonamer peptide from influenza A matrix peptide and the role of pockets of HLA-A2 in its recognition by cytolytic T lymphocytes. Eur J Immunol. 22:1992;903.
5. Moss PA, Moots RJ, Rosenburg WM, Rowland-Jones SJ, Bodmer HC, McMichael AJ, Bell JI. Extensive conservation of alpha and beta chains of the human T cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA. 88:1991;8987.
6. Vidal K, Hsu BL, Williams CB, Allen PM. Endogenous altered peptide ligands can affect peripheral T cell responses. J Exp Med. 183:1996;1311.
7. Bevan MJ, Hogquist KA, Jameson SC. Selecting the T cell receptor repertoire. Science. 264:1994;796.
8. Hogquist KA, Jameson SC, Bevan MJ. The ligand for positive selection of T lymphocytes in the thymus. Curr Opin Immunol. 6:1994;273.
9. Jameson SC, Hogquist KA, Bevan MJ. Specificity and flexibility in thymic selection. Nature. 369:1994;750.
10. Kuzushima K, Sun R, van Bleek GM, Vegh Z, Nathenson SG. The role of self peptides in the allogeneic cross-reactivity of CTLs. J Immunol. 154:1995;594.
11. Lehner PJ, Wang EDY, Moss PAH, Williams S, Platt K, Friedman SM, Bell JI, Borysiewicz LK. Human HLA-A0201 - restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vβ17 gene segment. J Exp Med. 181:1995;79.
12. Ferrier P, Fontecilla-Camps JC, Bucchini D, Caillol DH, Jordan BR, Lemonnier FA. Altered structure of HLA class I heavy chains associated with mouse β2 microglobulin. Immunogenetics. 21:1985;321.
13. Connan F, Hlavac F, Hoebeke J, Guillet J-G, Choppin J. A simple assay for detection of peptides promoting the assembly of HLA class I molecules. Eur J Immunol. 24:1994;777.
14. Hlavac F, Connan F, Hoebeke J, Guillet J-G, Choppin J. Detection of peptide-dependent HLA variability by surface plasmon resonance. Mol Immunol. 33:1996;573.
15. Gnjatic S, Bressac-de Paillerets B, Guillet J-G, Choppin J. Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules. Eur J Immunol. 25:1995;1638.
16. Cerny A, Fowler P, Brothers MA, Houghton M, Sclhicht HJ, Chisari FV. Induction in vitro of a primary human antiviral cytotoxic T cell response. Eur J Immunol. 25:1995;627.
17. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science. 271:1996;1723.
18. Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. Specific T cell recognition of minimally homologous peptides: evidences for multiple endogenous ligands. Immunity. 2:1995;655.
19. + T-cell memory determined by clonal burst size. Nature. 369:1994;652.
20. Lau LL, Jamelson BD, Somasundaram T, Ahmed R. Cytotoxic T-cell memory without antigen. Nature. 369:1994;648.
21. Fung-Leung W-P, Wallace WA, Gray D, Sha WC, Pircher H, Teh HS, Loh DY, Mak TW. CD8 is needed for positive selection but differentially required for negative selection of T cells during thymic ontogeny. Eur J Immunol. 23:1993;212.
22. Killeen N, Moriarty A, Teh HS, Littman DR. Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells. J Exp Med. 176:1992;89.
23. Schönrich G, Strauß G, Müller K-P, Dustin L, Loh DY, Auphan N, Schmitt-Verhulst A-M, Arnold B, Hämmerling GJ. Distinct requirements of positive and negative selection for selecting cell type and CD8 interaction. J Immunol. 151:1993;4098.
24. Utz U, Koenig S, Coligan JE, Biddison WE. Presentation of three different viral peptides, HTLV-1 TAX, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. J Immunol. 149:1992;214.